Medicine guide

ALCON ATROPINE

As listed in the register: ALCON ATROPINE

1 % · solution

  • Prescription only
  • Eyes and ears
Active substance
Atropine Sulfate
Made by
Alcon Canada Inc

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Medicine groupEyes and earsS01FA01

Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet

How it works

From the US prescribing label for the same active substance (ATROPEN Auto-Injector). It describes the substance, not this exact product.

Atropine competitively blocks the effects of acetylcholine, including excess acetylcholine due to organophosphorus poisoning, at muscarinic cholinergic receptors on smooth muscle, cardiac muscle, secretory gland cells, and in peripheral autonomic ganglia and the central nervous system.

Peak level after3–60 min
Half-life20 min
Mostly cleared after≈ 1.7 hfive half-lives — our arithmetic
How the body breaks it down

Much of the drug is metabolized by enzymatic hydrolysis, particularly in the liver.

How it leaves the body

The unchanged drug excreted by urine is approximately 13 to 50%.

Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2022-09-15

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

United StatesNo exact match for this strength and form

European UnionNo exact match for this strength and form

SpainNo exact match for this strength and form

NetherlandsNo exact match for this strength and form

SwitzerlandNo exact match for this strength and form

Details

Made byAlcon Canada Inc
Active substanceAtropine Sulfate
Used inEyes and ears
Strength1 %
Formsolution
ClassificationS01FA01 · Eyes and ears
Routeophthalmic
Dispensing (as stated by the register)PRESCRIPTION
StatusMarketed
MarketedYes, according to the register
DIN00035017
DPD drug code254

Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician

Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.